BioCentury | Jul 13, 2019
Product Development

Why Merck is in infectious disease for the long haul

...to AureoGen Biosciences Inc.’s preclinical aureobasidin A derivatives to treat infectious disease, and partnered with OpGen Inc....
...Services (CMS), Baltimore, Md. Harvard University, Cambridge, Mass. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. OpGen Inc....
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...3/28/19 $345.0 $3,608.4 $4,608.4 28% Moleculin Biotech Inc. (NASDAQ:MBRX) (A) 3/28/19 $5.3 NA $56.5 NA OpGen Inc....
BioCentury | Feb 9, 2018
Financial News

OpGen raises $12M in private placement

...Infectious disease and diagnostic company OpGen Inc. (NASDAQ:OPGN) raised $12 million through the sale of 2.8 million...
...exercise price of $3.25. H.C. Wainwright acted as the placement agent. OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Alicia Parker OpGen Inc....
BioCentury | Aug 4, 2017
Financial News

Opgen raises $10M follow-on

...On July 13, infectious disease and diagnostic company OpGen Inc. (NASDAQ:OPGN) raised $10 million through the sale...
...share and a five-year warrant to purchase a share at $0.43. OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Alicia Parker OpGen Inc....
BioCentury | Jun 9, 2017
Financial News

OpGen proposes $10M follow-on

...and diagnostic company OpGen Inc. (NASDAQ:OPGN) proposed to raise up to $10 million in a follow-on. OpGen Inc....
...NASDAQ:OPGN) proposed to raise up to $10 million in a follow-on. OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Julian Zhu OpGen Inc....
BioCentury | Dec 2, 2016
Company News

OpGen, Merck deal

...to detect antimicrobial resistance. Merck will provide OpGen access to its bacterial pathogens archive, and OpGen...
...pharma will have access to OpGen's Lighthouse portal. The companies declined to provide financial terms. OpGen Inc....
...NASDAQ:OPGN), Gaithersburg, Md. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Business: Diagnostic Shannon Lehnbeuter Merck & Co. Inc. OpGen Inc....
BioCentury | May 16, 2016
Financial News

OpGen completes private placement of units

OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Business: Diagnostic, Bioinformatics, Pharmacogenetics Date completed: 2016-05-12 Type: Private placement of units Raised: $10.4 million Units: 9.1 million Price: $1.14 (unit) Shares after offering: 21.6 million Note: Each unit comprises...
BioCentury | Jul 13, 2015
Finance

Tiers, some fears

...5/6/15 $55.0 $151.4 $134.7 -11% HTG Molecular Diagnostics Inc. (NASDAQ:HTGM) 5/6/15 $50.0 $94.3 $76.1 -19% OpGen Inc....
BioCentury | May 11, 2015
Financial News

OpGen completes IPO

OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Business: Diagnostic, Bioinformatics, Pharmacogenetics Date completed: 2015-05-05 Type: IPO Raised: $17.1 million Shares: 2.9 million Price: $6 (unit) Shares after offering: 10.7 million Underwriters: Maxim Group; National Securities Overallotment: 427,500...
BioCentury | May 7, 2015
Financial News

IPO roundup: Adaptimmune, CoLucid, OpGen, HTG

...immunotherapy company Adaptimmune Therapeutics plc (NASDAQ:ADAP), migraine treatment developer CoLucid Pharmaceuticals Inc. (NASDAQ:CLCD), diagnostics company OpGen Inc....
...COL-144 ), its oral selective agonist of serotonin (5-HT1F) receptor, to treat acute migraine. OpGen...
...share and a five-year warrant to purchase another share at $6.60. The offering price valued OpGen...
Items per page:
1 - 10 of 47
BioCentury | Jul 13, 2019
Product Development

Why Merck is in infectious disease for the long haul

...to AureoGen Biosciences Inc.’s preclinical aureobasidin A derivatives to treat infectious disease, and partnered with OpGen Inc....
...Services (CMS), Baltimore, Md. Harvard University, Cambridge, Mass. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. OpGen Inc....
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...3/28/19 $345.0 $3,608.4 $4,608.4 28% Moleculin Biotech Inc. (NASDAQ:MBRX) (A) 3/28/19 $5.3 NA $56.5 NA OpGen Inc....
BioCentury | Feb 9, 2018
Financial News

OpGen raises $12M in private placement

...Infectious disease and diagnostic company OpGen Inc. (NASDAQ:OPGN) raised $12 million through the sale of 2.8 million...
...exercise price of $3.25. H.C. Wainwright acted as the placement agent. OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Alicia Parker OpGen Inc....
BioCentury | Aug 4, 2017
Financial News

Opgen raises $10M follow-on

...On July 13, infectious disease and diagnostic company OpGen Inc. (NASDAQ:OPGN) raised $10 million through the sale...
...share and a five-year warrant to purchase a share at $0.43. OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Alicia Parker OpGen Inc....
BioCentury | Jun 9, 2017
Financial News

OpGen proposes $10M follow-on

...and diagnostic company OpGen Inc. (NASDAQ:OPGN) proposed to raise up to $10 million in a follow-on. OpGen Inc....
...NASDAQ:OPGN) proposed to raise up to $10 million in a follow-on. OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Julian Zhu OpGen Inc....
BioCentury | Dec 2, 2016
Company News

OpGen, Merck deal

...to detect antimicrobial resistance. Merck will provide OpGen access to its bacterial pathogens archive, and OpGen...
...pharma will have access to OpGen's Lighthouse portal. The companies declined to provide financial terms. OpGen Inc....
...NASDAQ:OPGN), Gaithersburg, Md. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Business: Diagnostic Shannon Lehnbeuter Merck & Co. Inc. OpGen Inc....
BioCentury | May 16, 2016
Financial News

OpGen completes private placement of units

OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Business: Diagnostic, Bioinformatics, Pharmacogenetics Date completed: 2016-05-12 Type: Private placement of units Raised: $10.4 million Units: 9.1 million Price: $1.14 (unit) Shares after offering: 21.6 million Note: Each unit comprises...
BioCentury | Jul 13, 2015
Finance

Tiers, some fears

...5/6/15 $55.0 $151.4 $134.7 -11% HTG Molecular Diagnostics Inc. (NASDAQ:HTGM) 5/6/15 $50.0 $94.3 $76.1 -19% OpGen Inc....
BioCentury | May 11, 2015
Financial News

OpGen completes IPO

OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Business: Diagnostic, Bioinformatics, Pharmacogenetics Date completed: 2015-05-05 Type: IPO Raised: $17.1 million Shares: 2.9 million Price: $6 (unit) Shares after offering: 10.7 million Underwriters: Maxim Group; National Securities Overallotment: 427,500...
BioCentury | May 7, 2015
Financial News

IPO roundup: Adaptimmune, CoLucid, OpGen, HTG

...immunotherapy company Adaptimmune Therapeutics plc (NASDAQ:ADAP), migraine treatment developer CoLucid Pharmaceuticals Inc. (NASDAQ:CLCD), diagnostics company OpGen Inc....
...COL-144 ), its oral selective agonist of serotonin (5-HT1F) receptor, to treat acute migraine. OpGen...
...share and a five-year warrant to purchase another share at $6.60. The offering price valued OpGen...
Items per page:
1 - 10 of 47